TACROLIMUS

Course overview

TACROLIMUS IS A MEDICATION USED IN THE PREVENTION AND TREATMENT OF SOLID-ORGAN TRANSPLANT REJECTION. IT IS IN THE CALCINEURIN-INHIBITOR CLASS OF MEDICATIONS. THIS ACTIVITY OUTLINES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR TACROLIMUS AS A VALUABLE AGENT IN THE PREVENTION OF SOLID-ORGAN TRANSPLANT REJECTION (AND OTHER DISORDERS WHEN APPLICABLE). THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT AND CARE OF PATIENTS POST SOLID-ORGAN TRANSPLANT.